SpaceX's $123 Billion Lockup Cliff: The Largest Supply Shock Since the IPO Itself

The quiet indicator that matters most this week isn’t on any earnings calendar. It’s a date: August 6, 2026. Two days after SpaceX reports its first quarterly results as a public company, the first major tranche of insider lockup restrictions expires, releasing roughly 911.5 million shares — valued at approximately $123 billion at recent prices — into a market that has already pushed the stock below its IPO price^[1].

SpaceX went public on June 11, 2026, listing on Nasdaq under the ticker SPCX at $135 per share in the largest IPO in US history^[1]. Less than seven weeks later, the stock trades at $111.09 as of 12:45 ET on July 27 — down roughly 18% from the offer price and 3.5% on the day^[2]. The stock has been sliding for weeks, touching an all-time low of $132.15 on July 23 before continuing its descent^[3].

The unlock schedule is what makes this structure unusual — and what makes the early-warning signal worth examining carefully.

The Staggered Cliff

Rather than the standard 180-day single lockup that most IPOs use, SpaceX implemented a staggered release schedule. Tranches of roughly 7% of total shares unlock at days 70, 90, 105, 120, and 135 after the IPO^[1].

The first major wave — estimated at 20% to 30% of total shares — lands approximately two trading days after the company reports Q2 earnings on August 4. That puts the unlock at August 6, meaning the stock will simultaneously be digesting financial results and absorbing a massive supply increase^[1]. A second large tranche of about 28% follows after Q3 earnings. By December 8, 2026, when the full 180-day period concludes, roughly 40% of all SpaceX shares will be freely tradable^[1].

Elon Musk’s personal shares carry a 366-day lockup, meaning he cannot sell until approximately June 2027^[1]. That removes the most visible potential seller from the equation but does nothing to prevent pre-IPO investors, employees, and early backers from pressing the exit.

The math gets uncomfortable quickly. At launch, less than 5% of SpaceX’s total shares were released into the public float^[1]. The float that the market has been price-discovering since June is a fraction of what’s coming. If even a modest percentage of unlocked holders decide to sell, the supply increase will dwarf anything the stock has experienced in its brief public life.

What the Price Is Already Telling Us

An 18% decline in the first seven weeks of trading is not a crisis, but it is a signal. The stock’s slide below $135 means every incremental seller who received shares at the IPO price is now looking at a loss. That changes the psychology of the unlock: holders who expected a premium are sitting underwater, and the decision to hold through the first tranche now carries a real cost-benefit calculation rather than a straightforward “lock in gains” choice.

The broader market context adds another layer. A former Nasdaq CEO has warned that the lockup structure is “unprecedented” and could ultimately flood the market with as much as $800 billion in shares over the full unlock schedule^[4]. That figure represents the total value of all locked shares, not the first tranche — but it underscores the scale of the supply overhang that will weigh on the stock for the next five months.

The critical question is not whether unlocked holders will sell — some will, mechanically — but whether the market’s appetite is deep enough to absorb the supply without a cascading effect. Index funds will need to increase their SpaceX weightings as the free float grows, which could provide a partial natural bid^[3]. But the timing of that passive demand is mechanical and gradual, while the unlocked supply arrives in discrete clumps.

CXMT’s Record Debut: The Other Side of the World

While SpaceX tests the US market’s capacity to absorb supply, a very different IPO story unfolded today in Shanghai. CXMT — China’s largest DRAM memory chipmaker — surged as much as 471.6% in its first trading session on the Shanghai STAR Market, making it China’s most valuable listed company^[5].

The Hefei-based company raised 57.92 billion yuan (approximately $8.6 billion) in its IPO, pricing shares at RMB 8.66^[5]. The stock opened at RMB 49.50 and touched RMB 55.03 during the session^[5]. At its peak, CXMT’s market capitalization reached approximately 3.28 trillion yuan ($485 billion), surpassing Intel’s market cap and reshaping the global memory-chip competitive landscape^[5].

CXMT held a 7.67% share of the global DRAM market in 2025, according to its IPO prospectus^[5]. The company plans to use IPO proceeds mainly for mass-producing memory wafers^[5]. The debut was the largest IPO in mainland China in recent years and underscores the divergent appetite for new listings between US and Chinese exchanges — where retail-driven first-day pops of this magnitude remain possible.

Whether CXMT’s valuation proves durable is a separate question. A 466% first-day gain on a company with under 8% global market share invites the same scrutiny that SpaceX’s $2 trillion-plus valuation has drawn. But for market structure, the signal is that the global IPO pipeline is functioning at scale on both sides of the Pacific, even as individual deals produce wildly different outcomes.

Jersey Mike’s: The $1 Billion Restaurant Test

Back in the US, the IPO calendar this week is led by Jersey Mike’s Subs, the Blackstone-backed sandwich chain that launched its roadshow on July 20, 2026^[6]. The company plans to raise approximately $1.0 billion by offering 43.5 million shares at a price range of $21 to $25 on NYSE under the ticker JMKE^[6][7].

At the $23 midpoint, the deal implies a market cap near $7.3 billion^[6]. Notably, approximately 68% of the offering is secondary — meaning existing holders are selling alongside the company’s primary raise^[6]. That structure means a meaningful portion of the proceeds goes to selling stockholders rather than the company’s balance sheet.

Jersey Mike’s has over 3,000 franchised locations across the US and is approximately 99% franchised^[6]. The deal tests whether investors will stretch for restaurant IPO valuations at a time when the broader IPO market is showing mixed results — and whether a PE-backed secondary-heavy structure will find demand at the high end of the range.

The Renaissance Capital calendar lists four additional deals this week: Reformation (REF) targeting $225 million, Apnimed (APMD) targeting $150 million, Ionic Digital (IOND), and River City Bank (RCBC) targeting $136 million^[7].

The 2026 IPO Scorecard So Far

Through July 27, 2026, there have been 208 IPOs on the US stock market — up 6.12% from the same date in 2025, which had 196 listings^[8]. The composition skews heavily toward SPACs ($10 unit offerings dominate the count), but the operational IPOs show a wide dispersion of outcomes:

Source: StockAnalysis.com, as of July 27, 2026^[8]; SPCX price from FMP quote snapshot^[2].

The pattern is familiar to anyone who watches IPO cycles: a handful of strong debuts (Scribe Therapeutics, Bending Spoons), a long tail of SPACs trading flat to slightly below $10, and several high-profile disappointments. The dispersion is wide, and the SPAC-heavy composition means the headline count overstates the amount of genuine new operating-company issuance.

What to Watch Next

1. August 4 — SpaceX Q2 earnings. The first financial report as a public company will set the tone for what follows two days later. Revenue trajectory, Starship development costs, and any commentary on the Starlink business will all be parsed for whether they justify a $2 trillion-plus valuation.

2. August 6 — First major lockup tranche. Approximately 20-30% of total shares become eligible for sale. The first few trading sessions after the unlock will reveal how much pent-up selling pressure exists and whether passive index demand can absorb it. Watch volume, bid-ask spread behavior, and whether the stock holds above its recent lows.

3. Jersey Mike’s pricing (expected ~July 30). Where the deal prices within the $21-$25 range will signal investor appetite for PE-backed consumer IPOs. A pricing at or above the midpoint would suggest demand is holding; a cut to the low end or below would be a cooler signal.

4. CXMT’s second-session performance. First-day pops of 466% on Chinese exchanges often face sharp reversals in subsequent sessions as retail momentum fades. Whether CXMT holds its valuation or retraces will say something about the durability of China’s IPO reopening.

5. The broader supply calendar. With 208 US IPOs already this year and a steady cadence of SPACs plus operational deals, the question is whether the pipeline can sustain its pace through the back half of 2026 — or whether the SpaceX lockup overhang, if it triggers volatility, causes issuers to pull deals the way they did in early 2026 when volatility spiked^[4].

The signal to monitor is not any single day’s price action but the interaction between the unlock schedule, the earnings catalyst, and the depth of demand. If the first tranche is absorbed without a material break below the stock’s recent trading range, that would suggest the market’s capacity for this supply is larger than the headline $123 billion figure implies. If it isn’t, the subsequent tranches at days 90, 105, 120, and 135 will each arrive into a market that has already been conditioned to expect weakness — and that is the escalation pattern worth watching for.